Interest of Tecartherapy on a Painful Caesarean Section Scar: a Randomized Clinical Trial. (NOCEPAIN)
Sponsor: University Hospital, Clermont-Ferrand
Terminated
Our low recruitment is related to the fact that few women are in pain in our department 6 to 8 weeks postpartum. It was therefore decided not to extend this study.
Other terminated trials from University Hospital, Clermont-Ferrand
- DSM-5 Schizophrenia · Feb 2026
- Catheterization, Peripheral Venous · Phase NA · Nov 2025
- Living in an Isolated Area · Phase NA · Mar 2025
- Bone · Phase NA · Apr 2024
- Atherosclerosis · Phase NA · Sep 2023
See all terminations from University Hospital, Clermont-Ferrand
Other Abdominal Pain trials with similar outcome
This NA trial investigates Abdominal Pain and Cesarean Section and is currently terminated or withdrawn. University Hospital, Clermont-Ferrand leads this study, which shows 10 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2025 — Dec 2025 [monthly]
Recruiting NA
Status: Unknown → Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2023 — Aug 2023 [monthly]
Not Yet Recruiting NA
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Not Yet Recruiting NA
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .